Real-World Patient Characteristics, Treatment Patterns, and Mutation Testing Patterns Among US Patients with Advanced Non-Small Cell Lung Cancer Harboring EGFR Mutations
Crossref DOI link: https://doi.org/10.1007/s12325-022-02189-z
Published Online: 2022-06-08
Published Print: 2022-07
Update policy: https://doi.org/10.1007/springer_crossmark_policy
He, Jinghua
Pericone, Christopher D.
Vanderpoel, Julie
Funding for this research was provided by:
Janssen Pharmaceuticals
Text and Data Mining valid from 2022-06-08
Version of Record valid from 2022-06-08
Article History
Received: 22 March 2022
Accepted: 11 May 2022
First Online: 8 June 2022